Performance of 18F-FDG PET/contrast-enhanced CT in the staging of squamous cell carcinoma of the oral cavity and oropharynx

International Journal of Oral and Maxillofacial Surgery

Volumn 40, Issue 11, 2011, Pages 1263-1270

  Krabbe, C A ^a,b   Balink, H ^b   Roodenburg, J L N ^a   Dol, J ^b   De Visscher, J G A M ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

FDG PET; head and neck cancer; PET CT; positron emission tomography; squamous cell carcinoma; tumour staging

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; NECK DISSECTION; ORAL AND OROPHARYNGEAL SQUAMOUS CELL CARCINOMA; OROPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; EVALUATION; IMAGE QUALITY; METHODOLOGY; MIDDLE AGED; MOUTH TUMOR; OROPHARYNX TUMOR; PATHOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 82955248076     PISSN: 09015027     EISSN: 13990020     Source Type: Journal    
DOI: 10.1016/j.ijom.2011.06.023     Document Type: Article

References (42)

1. M.C. Adams, T.G. Turkington, J.M. Wilson, and T.Z. Wong A systematic review of the factors affecting accuracy of SUV measurements AJR 195 2010 310 320
2. 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer Eur J Nucl Med 25 1998 1255 1260 (Pubitemid 28446051)
3. G. Antoch, H. Kuehl, J. Kanja, T.C. Lauenstein, H. Schneemann, E. Hauth, W. Jentzen, T. Beyer, S.C. Goehde, and J.F. Debatin Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation Radiology 230 2004 879 885 (Pubitemid 38252890)
4. T.S. Atula, M.J. Varpula, T.J. Kurki, P.J. Klemi, and R. Grenman Assessment of cervical lymph node status in head and neck cancer patients: palpation, computed tomography and low field magnetic resonance imaging compared with ultrasound-guided fine-needle aspiration cytology Eur J Radiol 25 1997 152 161 (Pubitemid 27372137)
5. B.F. Branstetter, T.M. Blodgett, L.A. Zimmer, C.H. Snyderman, J.T. Johnson, S. Raman, and C.C. Meltzer Head and neck malignancy: is PET/CT more accurate than PET or CT alone? Radiology 235 2005 580 586 (Pubitemid 40571100)
6. J. Brouwer, R. de Bree, E.F. Comans, J.A. Castelijns, O.S. Hoekstra, and C.R. Leemans Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: is it likely to be superior? Eur Arch Otorhinolaryngol 261 2004 479 483 (Pubitemid 39506424)
7. C.A. Connell, J. Corry, A.D. Milner, A. Hogg, R.J. Hicks, D. Rischin, and L.J. Peters Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma Head Neck 29 2007 986 995
8. E.J. Escott Positron emission tomography-computed tomography protocol considerations for head and neck cancer imaging Semin Ultrasound CT MR 29 2008 263 270
9. A.J. Fleming Jr., and M.E. Johansen The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients Curr Opin Otolaryngol Head Neck Surg 16 2008 127 134 (Pubitemid 351354967)
10. 18F-FDG positron emission tomography on previously untreated head and neck cancer patients Laryngoscope 117 2007 1173 1179 (Pubitemid 47015665)
11. G.W. Goerres, B. Schuknecht, D.T. Schmid, S.J. Stoeckli, and T.F. Hany Positron emission tomography/computed tomography for staging and restaging of head and neck cancer: comparison with positron emission tomography read together with contrast-enhanced computed tomography Clin Imaging 32 2008 431 437
12. H.S. Jeong, C.H. Baek, Y.I. Son, M. Ki Chung, D. Kyung Lee, J. Young Choi, B.T. Kim, and H.J. Kim Use of integrated FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma Head Neck 29 2007 203 210
13. C.A. Krabbe, P.U. Dijkstra, J. Pruim, B.F. van der Laan, J.E. van der Wal, J.P. Gravendeel, and J.L. Roodenburg FDG PET in oral and oropharyngeal cancer. Value for confirmation of N0 neck and detection of occult metastases Oral Oncol 44 2008 31 36 (Pubitemid 350251277)
14. C.A. Krabbe, J. Pruim, B.F. van der Laan, L.A. Rodiger, and J.L. Roodenburg FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT Oral Oncol 45 2009 234 240
15. 18F-FDG PET: a comparison with conventional methods Eur J Nucl Med 28 2001 816 821 (Pubitemid 32662543)
16. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis J Natl Cancer Inst 100 2008 712 720
17. C.R. Leemans, R. Tiwari, J.J. Nauta, I. van der Waal, and G.B. Snow Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma Cancer 71 1993 452 456 (Pubitemid 23021234)
18. D. Lum, S. Wandell, J. Ko, and M. Coel 1. Positron emission tomography of thoracic malignancies. Reduction of myocardial fluorodeoxyglucose uptake artifacts with a carbohydrate restricted diet Clin Positron Imaging 3 2000 155
19. Y. Menda, and M.M. Graham Update on (18)F-fluorodeoxyglucose/positron emission tomography and positron emission tomography/computed tomography imaging of squamous head and neck cancers Semin Nucl Med 35 2005 214 219 (Pubitemid 41253360)
20. C. Nahmias, E.R. Carlson, L.D. Duncan, T.M. Blodgett, J. Kennedy, M.J. Long, C. Carr, K.F. Hubner, and D.W. Townsend Positron emission tomography/computerized tomography (PET/CT) scanning for preoperative staging of patients with oral/head and neck cancer J Oral Maxillofac Surg 65 2007 2524 2535 (Pubitemid 350100969)
21. S.H. Ng, T.C. Yen, J.T. Chang, S.C. Chan, S.F. Ko, H.M. Wang, L.Y. Lee, C.J. Kang, A.M. Wong, and C.T. Liao Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck J Clin Oncol 24 2006 4371 4376 (Pubitemid 46646246)
22. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation J Nucl Med 46 2005 1136 1143 (Pubitemid 43741075)
23. 18F-FDG-PET/CT for staging of oral squamous cell carcinoma Head Neck 30 2008 1488 1496
24. 18F-FDG PET/CT for diagnosing cervical nodal metastases in patients with oral cavity or oropharynx carcinoma Oral Surg Oral Med Oral Pathol Oral Rad Endod 108 2009 933 938
25. 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma J Nucl Med 48 Suppl 1 2007 58S 67S (Pubitemid 47604943)
26. P. Reinartz, F.J. Wieres, W. Schneider, A. Schur, and U. Buell Side-by-side reading of PET and CT scans in oncology: which patients might profit from integrated PET/CT? Eur J Nucl Med Mol Imaging 31 2004 1456 1461 (Pubitemid 39592763)
27. R.S. Rodrigues, F.A. Bozza, P.E. Christian, J.M. Hoffman, R.I. Butterfield, C.R. Christensen, M. Heilbrun, R.H. Wiggins 3rd, J.P. Hunt, B.G. Bentz, Y.J. Hitchcock, and K.A. Morton Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck J Nucl Med 50 2009 1205 1213
28. S.N. Rogers, J.S. Brown, J.A. Woolgar, D. Lowe, P. Magennis, R.J. Shaw, D. Sutton, D. Errington, and D. Vaughan Survival following primary surgery for oral cancer Oral Oncol 45 2009 201 211
29. J.L. Roh, N.K. Yeo, J.S. Kim, J.H. Lee, K.J. Cho, S.H. Choi, S.Y. Nam, and S.Y. Kim Utility of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma Oral Oncol 43 2007 887 893 (Pubitemid 47369251)
30. 18F-FDG PET/CT for detecting nodal metastases in patients with oral cancer staged N0 by clinical examination and CT/MRI J Nucl Med 47 2006 755 762 (Pubitemid 46768437)
31. H. Schoder, H.W. Yeung, M. Gonen, D. Kraus, and S.M. Larson Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion Radiology 231 2004 65 72 (Pubitemid 38375411)
32. U. Schroeder, M. Dietlein, C. Wittekindt, M. Ortmann, H. Stuetzer, J. Vent, M. Jungehuelsing, and B. Krug Is there a need for positron emission tomography imaging to stage the N0 neck in T1-T2 squamous cell carcinoma of the oral cavity or oropharynx? Ann Otol Rhinol Laryngol 117 2008 854 863
33. A.M. Scott, D.H. Gunawardana, D. Bartholomeusz, J.E. Ramshaw, and P. Lin PET changes management and improves prognostic stratification in patients with head and neck cancer: results of a multicenter prospective study J Nucl Med 49 2008 1593 1600
34. A. Senft, R. de Bree, O.S. Hoekstra, D.J. Kuik, R.P. Golding, W.J. Oyen, J. Pruim, F.J. van den Hoogen, J.L. Roodenburg, and C.R. Leemans Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial Radiother Oncol 87 2008 221 229
35. R. Syed, J.B. Bomanji, N. Nagabhushan, S. Hughes, I. Kayani, A. Groves, S. Gacinovic, N. Hydes, D. Visvikis, C. Copland, and P.J. Ell Impact of combined (18)F-FDG PET/CT in head and neck tumours Br J Cancer 92 2005 1046 1050 (Pubitemid 40546667)
36. M.W.M. Van den Brekel Lymphnode metastases: CT and MRI Eur J Radiol 33 2000 230 238
37. P. Veit-Haibach, C. Luczak, I. Wanke, M. Fischer, T. Egelhof, T. Beyer, G. Dahmen, A. Bockisch, S. Rosenbaum, and G. Antoch TNM staging with FDG-PET/CT in patients with primary head and neck cancer Eur J Nucl Med Mol Imaging 34 2007 1953 1962 (Pubitemid 350212141)
38. M.H. Weiss, L.B. Harrison, and R.S. Isaacs Use of decision analysis in planning a management strategy for the stage N0 neck Arch Otolaryngol Head Neck Surg 120 1994 699 702 (Pubitemid 24217580)
39. W.L. Wong, D. Gibson, B. Sanghera, K. Goodchild, and M. Saunders Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: a PET CT study Nucl Med Commun 28 2007 675 680 (Pubitemid 47220400)
40. Y. Yamamoto, T.Z. Wong, T.G. Turkington, T.C. Hawk, and R.E. Coleman Head and neck cancer: dedicated FDG PET/CT protocol for detection - phantom and initial clinical studies Radiology 224 2007 263 272 (Pubitemid 46981982)
41. H.W. Yeung, H. Schoder, A. Smith, M. Gonen, and S.M. Larson Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography studies in cancer patients Mol Imaging Biol 7 2005 229 235 (Pubitemid 41348865)
42. 18F-FDG positron emission/computerized tomography for head and neck tumors Laryngoscope 115 2005 1186 1190 (Pubitemid 40962353)